BACKGROUND: As next generation sequencing (NGS) technologies have experienced a rapid development over the last decade, the investigation of the bacterial genetic architecture reveals a high potential to dissect causal loci of antibiotic resistance phenotypes. Although genome-wide association studies (GWAS) have been successfully applied for investigating the basis of resistance traits, complex resistance phenotypes have been omitted so far. For S. aureus this especially refers to antibiotics of last resort like daptomycin and ceftaroline. Therefore, we aimed to perform GWAS for the identification of genetic variants associated with DAP and CPT resistance in clinical S. aureus isolates. MATERIALS/ METHODS: To conduct microbial GWAS, we selected cases and controls according to their clonal background, date of isolation, and geographical origin. Association testing was performed with PLINK and SEER analysis. By using in silico analysis, we also searched for rare genetic variants in candidate loci that have previously been described to be involved in the development of corresponding resistance phenotypes. RESULTS: GWAS revealed MprF P314L and L826F to be significantly associated with DAP resistance. These mutations were found to be homogenously distributed among clonal lineages suggesting convergent evolution. Additionally, rare and yet undescribed single nucleotide polymorphisms could be identified within mprF and putative candidate genes. Finally, we could show that each DAP resistant isolate exhibited at least one amino acid substitution within the open reading frame of mprF. Due to the presence of strong population stratification, no genetic variants could be associated with CPT resistance. However, the investigation of the staphylococcal cassette chromosome mec (SCCmec) revealed various mecA SNPs to be putatively linked with CPT resistance. Additionally, some CPT resistant isolates revealed no mecA mutations, supporting the hypothesis that further and still unknown resistance determinants are crucial for the development of CPT resistance in S. aureus. CONCLUSION: We hereby confirmed the potential of GWAS to identify genetic variants that are associated with antibiotic resistance traits in S. aureus. However, precautions need to be taken to prevent the detection of spurious associations. In addition, the implementation of different approaches is still essential to detect multiple forms of variations and mutations that occur with a low frequency.
BACKGROUND: As next generation sequencing (NGS) technologies have experienced a rapid development over the last decade, the investigation of the bacterial genetic architecture reveals a high potential to dissect causal loci of antibiotic resistance phenotypes. Although genome-wide association studies (GWAS) have been successfully applied for investigating the basis of resistance traits, complex resistance phenotypes have been omitted so far. For S. aureus this especially refers to antibiotics of last resort like daptomycin and ceftaroline. Therefore, we aimed to perform GWAS for the identification of genetic variants associated with DAP and CPT resistance in clinical S. aureus isolates. MATERIALS/ METHODS: To conduct microbial GWAS, we selected cases and controls according to their clonal background, date of isolation, and geographical origin. Association testing was performed with PLINK and SEER analysis. By using in silico analysis, we also searched for rare genetic variants in candidate loci that have previously been described to be involved in the development of corresponding resistance phenotypes. RESULTS: GWAS revealed MprF P314L and L826F to be significantly associated with DAP resistance. These mutations were found to be homogenously distributed among clonal lineages suggesting convergent evolution. Additionally, rare and yet undescribed single nucleotide polymorphisms could be identified within mprF and putative candidate genes. Finally, we could show that each DAP resistant isolate exhibited at least one amino acid substitution within the open reading frame of mprF. Due to the presence of strong population stratification, no genetic variants could be associated with CPT resistance. However, the investigation of the staphylococcal cassette chromosome mec (SCCmec) revealed various mecA SNPs to be putatively linked with CPT resistance. Additionally, some CPT resistant isolates revealed no mecA mutations, supporting the hypothesis that further and still unknown resistance determinants are crucial for the development of CPT resistance in S. aureus. CONCLUSION: We hereby confirmed the potential of GWAS to identify genetic variants that are associated with antibiotic resistance traits in S. aureus. However, precautions need to be taken to prevent the detection of spurious associations. In addition, the implementation of different approaches is still essential to detect multiple forms of variations and mutations that occur with a low frequency.
Authors: Claire Chewapreecha; Matthew T G Holden; Minna Vehkala; Niko Välimäki; Zhirong Yang; Simon R Harris; Alison E Mather; Apichai Tuanyok; Birgit De Smet; Simon Le Hello; Chantal Bizet; Mark Mayo; Vanaporn Wuthiekanun; Direk Limmathurotsakul; Rattanaphone Phetsouvanh; Brian G Spratt; Jukka Corander; Paul Keim; Gordon Dougan; David A B Dance; Bart J Currie; Julian Parkhill; Sharon J Peacock Journal: Nat Microbiol Date: 2017-01-23 Impact factor: 17.745
Authors: Richard A Alm; Robert E McLaughlin; Veronica N Kos; Helio S Sader; Joseph P Iaconis; Sushmita D Lahiri Journal: J Antimicrob Chemother Date: 2014-04-28 Impact factor: 5.790
Authors: Lucy A Weinert; Roy R Chaudhuri; Jinhong Wang; Sarah E Peters; Jukka Corander; Thibaut Jombart; Abiyad Baig; Kate J Howell; Minna Vehkala; Niko Välimäki; David Harris; Tran Thi Bich Chieu; Nguyen Van Vinh Chau; James Campbell; Constance Schultsz; Julian Parkhill; Stephen D Bentley; Paul R Langford; Andrew N Rycroft; Brendan W Wren; Jeremy Farrar; Stephen Baker; Ngo Thi Hoa; Matthew T G Holden; Alexander W Tucker; Duncan J Maskell Journal: Nat Commun Date: 2015-03-31 Impact factor: 14.919
Authors: R L Richards; R D Haigh; B Pascoe; S K Sheppard; F Price; D Jenkins; K Rajakumar; J A Morrissey Journal: Infect Immun Date: 2015-06-08 Impact factor: 3.441
Authors: Md Tauqeer Alam; Robert A Petit; Emily K Crispell; Timothy A Thornton; Karen N Conneely; Yunxuan Jiang; Sarah W Satola; Timothy D Read Journal: Genome Biol Evol Date: 2014-04-30 Impact factor: 3.416
Authors: Erica Lasek-Nesselquist; Jackson Lu; Ryan Schneider; Zhuo Ma; Vincenzo Russo; Smruti Mishra; Manjunath P Pai; Janice D Pata; Kathleen A McDonough; Meenakshi Malik Journal: Front Microbiol Date: 2019-02-28 Impact factor: 5.640
Authors: J Chase McNeil; Lauren M Sommer; Jesus G Vallejo; Kristina G Hulten; Sheldon L Kaplan; Anthony R Flores Journal: Antimicrob Agents Chemother Date: 2022-09-27 Impact factor: 5.938
Authors: Anna Sommer; Stephan Fuchs; Franziska Layer; Christoph Schaudinn; Robert E Weber; Hugues Richard; Mareike B Erdmann; Michael Laue; Christopher F Schuster; Guido Werner; Birgit Strommenger Journal: Microb Genom Date: 2021-09
Authors: Maria Carla Martini; Nathan D Hicks; Junpei Xiao; Maria Natalia Alonso; Thibault Barbier; Jaimie Sixsmith; Sarah M Fortune; Scarlet S Shell Journal: PLoS Pathog Date: 2022-07-13 Impact factor: 7.464